NEWTON, Mass.--(BUSINESS WIRE)--Pro-Pharmaceuticals, Inc. (Amex: PRW), a company “Advancing Drugs Through Glycoscience®", today announced it has retained Camargo Pharmaceutical Services, LLC to provide strategic regulatory support for the Company’s 505(b)(2) submissions with the U.S. Food and Drug Administration (FDA).
